510(k) device
Total Immunoglobulin E (IgE)
Beckman Coulter, Inc. · Ige, Antigen, Antiserum, Control (DGC, Class II) · First FDA decision Mar 23, 2022, newest Mar 23, 2022Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
12
Naming "Immunoglobulin E"
MAUDE reports
5
Brand "Immunoglobulin E", since 2015
PubMed studies
12,171
Mentioning "Immunoglobulin E"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Total Immunoglobulin E (IgE)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K220178 · Decided Mar 23, 2022 · 61 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Immunoglobulin E", any status and sponsor, newest update first.
Karyopharm Therapeutics IncNot on our public-company list
NCT04421378 · 74 participants · Start Jun 8, 2020 · Primary completion Jul 3, 2023
Device: TTField · For: Glioblastoma Multiforme
Sites: Birmingham, Alabama; Los Angeles, California; San Francisco, California · 18 sites in all
- Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled AirStatus unknown
Hopital FochAcademic, hospital or other
NCT03988790 · 50 participants (planned) · Start Dec 4, 2018 · Primary completion Dec 31, 2022
Device: VOC analysis · For: Asthma
Sites: Suresnes, France
Novartis PharmaceuticalsNot on our public-company list
NCT02758548 · 193 participants · Start Mar 2016 · Primary completion May 2016
Device: POCT device · For: Atopic Asthma
Sites: Hamburg, Germany; Lübeck, Germany; Padova, Italy · 12 sites in all
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Immunoglobulin E", and for the whole product code for context.
This brand
5 reports: 5 malfunction, 0 injury, 0 death
Whole product code DGC
6 reports: 6 malfunction, 0 injury, 0 death
Newest reports for this brand
- IMMUNOGLOBULIN EMalfunction
1823260-2016-00369 · Received Mar 29, 2016 · Event dated Feb 25, 2016
Device type: Radioimmunoassay, Immunoglobulins (D, E) (JHR)
Device problem as coded: Incorrect Or Inadequate Test Results
Patient problem as coded: No Consequences Or Impact To Patient
- IMMUNOGLOBULIN EMalfunction
1823260-2016-00074 · Received Jan 26, 2016 · Event dated Dec 24, 2015
Device type: Radioimmunoassay, Immunoglobulins (D, E) (JHR)
Device problem as coded: High Test Results
Patient problem as coded: No Consequences Or Impact To Patient; Insufficient Information
- IMMUNOGLOBULIN EMalfunction
1823260-2015-04579 · Received Nov 18, 2015 · Event dated Oct 13, 2015
Device type: Radioimmunoassay, Immunoglobulins (D, E) (JHR)
Device problem as coded: Incorrect Or Inadequate Test Results
Patient problem as coded: No Known Impact Or Consequence To Patient
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Immunoglobulin E"[tiab]. The summary above synthesizes these.
- Immunoglobulin E-Mediated Autoimmunity.
Maurer M, Altrichter S, Schmetzer O, et al. · Front Immunol · 2018Review
- Food Allergy Testing.
LaHood NA, Patil SU · Clin Lab Med · 2019Research Support, N.I.H., Extramural, Review
- Immunoglobulin E.
Sarsfield JK · Dev Med Child Neurol · 1972
- Editorial: Allergic diseases and neurodevelopment.
Straughen JK, Kozyrskyj AL, Cassidy-Bushrow AE · Front Pediatr · 2023Editorial
- IgE, α-Gal and atherosclerosis.
Wilson JM, McNamara CA, Platts-Mills TAE · Aging (Albany NY) · 2019Editorial
- Immunoglobulin E and allergy.
Wagner B · Equine Vet J · 2016Comment, Editorial
- Editorial: Mast cells in allergic diseases.
Kubala S, Haque TT · Front Allergy · 2023Editorial
- Immunoglobulin E: From horses to myeloma.
Brown AJ · Cleve Clin J Med · 2026Editorial
- Immunoglobulin E receptors.
Gould H, Sutton B, Beavil A, et al. · Clin Exp Allergy · 1991Review
- Food allergy testing in atopic dermatitis.
Ramírez-Marín HA, Singh AM, Ong PY, et al. · JAAD Int · 2022
- The Mechanisms of Immunoglobulin E Sensitizations in Atopic Dermatitis.
Mukherjee S, Geha RS, Das M · Immunol Allergy Clin North Am · 2025Review, Research Support, N.I.H., Extramural
Other devices of this type
Also filed under product code DGC.
- Quantia IgEBiokit, S.A. · 510(k) 2023
- ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control StripPhadia AB · 510(k) 2016
- Kenota 1 Total IgEKenota, Inc. · 510(k) 2024
- ADVIA Centaur Total IgE (tIgE)Siemens Healthcare Diagnostics, Inc. · 510(k) 2020
- Dimension Vista Ige Flex Reagent CartridgeDade Behring, Inc. · 510(k) 2007
- K-Assay Total Ige, K-Assay Ige Calibrator Set, Models KAI-092/KAI-093CKamiya Biomedical Co. · 510(k) 2004
- LacrytestAdiatec SA · 510(k) 2004
- Immunetech Total Ige SystemImmunetech Corporation · 510(k) 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.